|
On (b)(6) 2025, a patient underwent placement of a venovo stent in the subclavian vein.Post procedure, the stent allegedly fractured and separated into two pieces and the fragments of stent were placed inside the patients.The current status of the patient is unknown.
|
|
H11: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.However, image was provided for review.The investigation of the reported event is currently underway.Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
H11: manufacturing review: based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: a single x-ray image was provided, showing one stent placed in the patient's chest.The stent is confirmed to be completely fractured across its entire diameter near the mid-length.However, the segments remains close to each other.There is no reduction in stent diameter and no other visible deformation; the stent strut pattern remains regular.There are no indication for a manufacturing related cause.Based on x-ray image provided, the reported stent fracture is confirmed.However, a definite root cause could not be determined.The reported placement of the venous stent in the subclavian vein represents an off label use of the device.Labeling review: the relevant labeling provided with this product was reviewed, and the potential issue was found to be addressed.According to the instructions for use (ifu) "stent fracture" is referenced to be a potential complications which may occur.Correct stent deployment procedure, as well as pre and post deployment procedure are properly described.A stent size selection table outlines the relationship between stent diameter and vessel diameter.The reported placement of the venous stent in the subclavian vein represents an off-label use of the device.According to the ifu supplied with this product, the venovo venous stent system is indicated for the treatment of symptomatic iliofemoral venous outflow obstruction.E1, g3, h6 (device, method, result, conclusion) section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
On (b)(6) 2025, a patient underwent placement of a venovo stent in the subclavian vein.Post the procedure, the stent allegedly fractured and separated into two pieces and the fragments of stent remained inside the patients.The current status of the patient was unknown.
|